Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Nat Commun ; 15(1): 4619, 2024 May 30.
Article in English | MEDLINE | ID: mdl-38816431

ABSTRACT

Since the first report on single-layer MoS2 based transistor, rapid progress has been achieved in two-dimensional (2D) material-based atomically thin electronics, providing an alternative approach to solve the bottleneck in silicon device miniaturization. In this scenario, reliable contact between the metal electrodes and the subnanometer-thick 2D materials becomes crucial in determining the device performance. Here, utilizing the quasi-van der Waals (vdW) epitaxy of metals on fluorophlogopite mica, we demonstrate an all-stacking method for the fabrication of 2D devices with high-quality vdW contacts by mechanically transferring pre-deposited metal electrodes. This technique is applicable for complex device integration with sizes up to the wafer scale and is also capable of tuning the electric characteristics of the interfacial junctions by transferring selective metals. Our results provide an efficient, scalable, and low-cost technique for 2D electronics, allowing high-density device integration as well as a handy tool for fundamental research in vdW materials.

2.
Ther Deliv ; 9(4): 245-255, 2018 03 01.
Article in English | MEDLINE | ID: mdl-29540127

ABSTRACT

AIM: To synthesize a puerarin nanoparticle based on glycyrrhetinic acid (GA)-PEG-PBLA and evaluate it in vivo. MATERIALS & METHODS: In this study, drug nanoparticle was synthesized, characterized and assessed as puerarin delivery system. Nanoparticle GA-PEG-PBLA could combine with puerarin via hydrophobic interaction to form the compound. Puerarin could be quickly and efficiently loaded via the nanoparticle GA-PEG-PBLA at pH 7.4. Further, GA-PEG-PBLA-mediated puerarin delivery system could target for the liver that had GA receptor binding. The antiliver ischemia/reperfusion injury role of puerarin/GA-PEG-PBLA was measured in rats using free puerarin and puerarin/PEG-PBLA as the controls. RESULTS: GA-PEG-PBLA displayed efficient loading and sustained release. Puerarin/GA-PEG-PBLA showed strengthened antiliver ischemia/reperfusion injury characteristics. CONCLUSION: Overall, the results show that GA-PEG-PBLA could be regarded as an underlying puerarin nanoparticle.


Subject(s)
Drug Carriers/chemistry , Isoflavones/pharmacology , Reperfusion Injury/drug therapy , Signal Transduction/drug effects , Vasodilator Agents/pharmacology , Animals , Cell Line , Disease Models, Animal , Glycyrrhetinic Acid/chemistry , Humans , Isoflavones/therapeutic use , Liver/blood supply , Liver/drug effects , Liver/pathology , NF-kappa B/metabolism , Nanoparticles/chemistry , Peptides/chemistry , Polyethylene Glycols/chemistry , Rats , Rats, Sprague-Dawley , Reperfusion Injury/etiology , Reperfusion Injury/pathology , Toll-Like Receptor 4/metabolism , Treatment Outcome , Vasodilator Agents/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...